Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GOLGA6GP (Golgin A6 family member G, pseudogene) is classified as a pseudogene, meaning it is a DNA sequence similar to a gene but is generally considered non-functional at the protein level and does not encode an active protein product[1]. Pseudogenes may arise from duplication or retrotransposition events and often accumulate mutations that prevent normal gene expression. While pseudogenes were once thought to be mere "junk DNA," research shows that some pseudogenes can be transcribed and may impact gene regulation, for example by acting as decoys for microRNAs or through generation of regulatory RNAs[2][3]. However, there is no evidence that GOLGA6GP itself is functional or involved in any therapeutic mechanism, nor is it considered a druggable target. Key points: - GOLGA6GP does not encode a protein or known receptor, enzyme, transporter, or transcription factor. - It is classified as a pseudogene and is likely non-functional, with no evidence of direct biological or disease relevance specific to itself[1]. - Some pseudogenes in general have been shown to play regulatory roles such as microRNA decoying or regulating gene expression, but these are not described for GOLGA6GP[2][3]. - No drugs, biomarkers, or known safety concerns are associated with this pseudogene. If you seek a therapeutic target or a molecule of functional biological significance, GOLGA6GP does not meet those criteria.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Golgin A6 family member G, pseudogene (GOLGA6GP).